Peripheral T Cell Lymphoma: Clinical Trials

2 trials for Peripheral T Cell Lymphoma, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 unknown. 2 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 42Unknown 2

Follow Peripheral T Cell Lymphoma: new trials by email Literature Review of Peripheral T Cell Lymphoma trials Research Report on Peripheral T Cell Lymphoma

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Combination Chemotherapy Including Cisplatin, Ifosfamide, Gemcitabine, L-asparaginase, Etoposide and Dexamethasone as Treatment of Newly Diagnosed and Relapsed/Refractory Peripheral T Cell Lymphomas
cisplatin, ifosfamide, gemcitabine - Peripheral T Cell Lymphoma
Phase 4UnknownThe University of Hong Kong502017-02-242018-06-11
A Pralatrexate Study in Asian Patients With Peripheral T-cell Lymphoma After Prior Therapy
Pralatrexate - Peripheral T Cell Lymphoma, Progression, Disease
Phase 4UnknownTaiwan Mundipharma Pharmaceuticals Ltd.222016-08-302017-05-12

Narrower conditions

Lymphoma, T-Cell, Peripheral (2)  ·  Disease Progression (1)

Broader conditions

Hemic and Lymphatic Diseases (2)  ·  Immune System Diseases (2)  ·  Immunoproliferative Disorders (2)  ·  Lymphatic Diseases (2)  ·  Lymphoma (2)  ·  Lymphoma, Non-Hodgkin (2)  ·  Lymphoma, T-Cell (2)  ·  Lymphoproliferative Disorders (2)  ·  Neoplasms (2)  ·  Neoplasms by Histologic Type (2)  ·  Disease Attributes (1)  ·  Pathologic Processes (1)  ·  Pathological Conditions, Signs and Symptoms (1)

Interventions

10-propargyl-10-deazaaminopterin (1)  ·  Asparaginase (1)  ·  Cisplatin (1)  ·  Dexamethasone (1)  ·  Etoposide (1)  ·  Gemcitabine (1)  ·  Ifosfamide (1)

Sponsors

Taiwan Mundipharma Pharmaceuticals Ltd. (1)  ·  The University of Hong Kong (1)

Countries

Hong Kong (1)  ·  Taiwan (1)

Top investigators

Bor-Sheng Ko, PhD (1)  ·  Yok Lam Kwong, MBBS (1)